[EN] AZAINDOLE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES<br/>[FR] DÉRIVÉS AZAINDOLE UTILISÉS EN TANT QU'INHIBITEURS DE PROTÉINE KINASES
申请人:ORIBASE PHARMA
公开号:WO2014102378A1
公开(公告)日:2014-07-03
The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
申请人:Albaugh Pamela
公开号:US20100029605A1
公开(公告)日:2010-02-04
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, ARG, BCR-Abl, BRK, EphB, Fms, Fyn, KDR, c-Kit, LCK, PDGF-R, b-Raf, c-Raf, SAPK2, Src, Tie2 and TrkB kinases.
AZAINDOLE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES
申请人:ORIBASE PHARMA
公开号:US20150353540A1
公开(公告)日:2015-12-10
The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.